Keywords: Canada, Rare diseases strategy, Orphan drugs, BIOTECanada, Rx&D

New Canadian rare disease strategy welcomed as offering hope and solutions for patients

Article | 04 October 2012

The Canadian government this week announced a new national framework to improve access to “orphan drugs” for people ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in